TISSUE PLASMINOGEN ACTIVATOR

摘要

Tissue plasminogen activator (tPA) derived from the non-cancerous mammalian cell line JMI-229 is found to have significantly greater binding affinity to human fibrin clots than currently available therapeutic-grade tPA, which is based on human tPA, thus exhibiting improved properties for potential therapeutic use.